Hyperglycemia is thought to enhance matrix metalloproteinase‐9 (MMP‐9) activity in the ischemic area during reperfusion, which reduces a junctional protein in endothelial cells and then results in blood–brain barrier (BBB) damage (Kamada, Yu, Nito, & Chan, 2007). Here, MMP9 is linked to Hyperglycemia.